SC 13G/A: Galera Therapeutics, Inc.

AI Summary

SC 13G/A filing by Galera Therapeutics, Inc..

Risk Assessment

Risk Level: low

Filing Documents

• altamont_sc13ga1.htm (SC 13G/A) — 43KB
• 0001683168-24-002071.txt ( ) — 45KB

If this statement is filed pursuant to §§240.13d-1(b)

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) Group, in accordance with §240.13d-1(b)(1)(ii)(J). 3 CUSIP No. 36338D108 13-G Page 4 of 5 Pages

Ownership

Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Altamont Pharmaceutical Holdings, LLC is the sole owner of 0 Shares of Common Stock of the Issuer. Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings, LLC. Under the definition of “beneficial ownership” in Rule 13d-3 under the Act, it is also possible that individuals, executive officers, and members of the foregoing entities might be deemed the “beneficial owners” of some or all of the securities insofar as they may be deemed to share in the power to direct the voting or disposition of the securities. Neither the filing of this Schedule nor any of its contents shall be deemed to constitute an admission that any of such individuals is, for any purpose, the beneficial owner of any of the Securities, and such beneficial ownership is expressly disclaimed. (a) Amount beneficially owned: · Altamont Pharmaceutical Holdings, LLC - 0 · Mark Pearson - 0 (b) Percent of class: Altamont Pharmaceutical Holdings, LLC – 0% · Mark Pearson – 0% (c) Number of shares as to which the person has: 0 (i) Sole power to vote or to direct the vote: · Altamont Pharmaceutical Holdings, LLC – 0 · Mark Pearson - 0 (ii) Shared power to vote or to direct the vote: · Altamont Pharmaceutical Holdings, LLC – 0 · Mark Pearson – 0 (iii) Sole power to dispose or to direct the disposition of: · Altamont Pharmaceutical Holdings, LLC – 0 · Mark Pearson - 0 (iv) Shared power to dispose or to direct the disposition of : · Altamont Pharmaceutical Holdings, LLC – 0 · Mark Pearson – 0 * Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings, LLC. As a result, Mark Pearson possesses the power to vote and dispose or

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following . Instruction . Dissolution of a group requires a response to this item.

Ownership of More than Five Percent on Behalf

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

is not applicable

Item 6 is not applicable.

Identification and Classification of the Subsidiary

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

is not applicable

Item 7 is not applicable.

Identification and Classification of Members

Item 8. Identification and Classification of Members of the Group.

is not applicable

Item 8 is not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group.

is not applicable

Item 9 is not applicable

Certification

Item 10. Certification. The following certification shall be included if the statement is filed pursuant to §240.13d-1(c): By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. 04/02/2024 Date /s/ Altamont Pharmaceutical Holdings, LLC By: Mark Pearson Signature Mark Pearson, Manager Name/Title 04/02/2024 Date /s/ Mark Pearson Signature Mark Pearson Name

View Full Filing

View this SC 13G/A filing on SEC EDGAR